“Being a medium sized company, we can be very flexible when forming strategic partnerships”
To remain in the leading group of pharmaceutical companies, Solvay Pharmaceuticals enters into strategic alliances with skilled partners. Over the years we have formed strategic partnerships with other pharmaceutical companies in order to provide patients with faster access to our medications.
Our scientific partners:
- With Bristol Myers Squibb in obesitas (press-release)
- With Wyeth Pharmaceuticals in CNS-disorders (press-release)
- With Luncbeck in Schizophrenia (press-release)
- With Petrovax in flu prevention (press-release)
- With Novozymes in pancreatic (press-release)
- With Zentaris in endometriosis (press-release)
- With Hormos in women’s health (press-release)
- With Innogenetics in molecular biology (press-release)
- With Quintiles/Pharmabio Development in clinical research (press-release)